metsera glp-1 Reports Highly Competitive Results from Ongoing Trial of Novel, Potential Once-Monthly Injectable Receptor Agonist MET-097 Pfizer dips on new data

Whether you prefer Lipo-GSH or SAG, we provide international-standard quality products and professional support

In the ATTAIN-2 trial, participants lost an average of 22.9 lbs (10.5 percent) on the highest (36mg) dose of orforglipron, with A1C reduced by an average of 1.8 percent

Pharmacokinetics of IL-18 Binding Protein in Healthy Volunteers and Subjects With Rheumatoid Arthritis or Plaque Psoriasis

These six expert-approved liver detox steps make the process safe, effective and sustainable

The combination of this medication is used for increasing the sperm count and treating male infertility

Weeks 4-8: Gradual improvements in baseline pain and function